Francois Sigaux

Paris, 75010, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.

Clonal hematopoiesis driven by chromosome 1q/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia.

Journal: Cell stem cell
Published: April 22, 2022

Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.

Concurrent CDX2 cis-deregulation and UBTF::ATXN7L3 fusion define a novel high-risk subtype of B-cell ALL.

Journal: Blood
Published: January 04, 2022

PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.

PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome.

Journal: Blood
Published: December 05, 2018

Deletion 6q Drives T-cell Leukemia Progression by Ribosome Modulation.

Deletion 6q Drives T-cell Leukemia Progression by Ribosome Modulation.

Journal: Cancer discovery
Published: July 30, 2017

Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia.

Genetic polymorphisms associated with increased risk of developing chronic myelogenous leukemia.

Journal: Oncotarget
Published: August 12, 2015

Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion.

Defective NK Cells in Acute Myeloid Leukemia Patients at Diagnosis Are Associated with Blast Transcriptional Signatures of Immune Evasion.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: February 04, 2015

SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.

SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.

Journal: Blood
Published: December 17, 2013

High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients.

High imatinib dose overcomes insufficient response associated with ABCG2 haplotype in chronic myelogenous leukemia patients.

Journal: Oncotarget
Published: October 15, 2013

Identification of TMEM131L as a novel regulator of thymocyte proliferation in humans.

Identification of TMEM131L as a novel regulator of thymocyte proliferation in humans.

Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: May 22, 2013

An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.

An intragenic ERG deletion is a marker of an oncogenic subtype of B-cell precursor acute lymphoblastic leukemia with a favorable outcome despite frequent IKZF1 deletions.

Journal: Leukemia
Published: May 07, 2013

Human skin carcinoma arising from kidney transplant-derived tumor cells.

Human skin carcinoma arising from kidney transplant-derived tumor cells.

Journal: The Journal of clinical investigation
Published: September 04, 2012

The power of one.

The power of one.

Journal: Science translational medicine
Published: April 21, 2012
Showing 1-12 of 13

Last Updated: 09/26/2026